Skin Research Institute, Hôpital Saint-Louis ,
The Pathogenesis of Systemic Sclerosis, Annual Review of Pathology: Mechanisms of Disease, vol.6, issue.1, pp.509-537, 2011. ,
DOI : 10.1146/annurev-pathol-011110-130312
Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis, Autoimmunity Reviews, vol.10, issue.2, pp.65-73, 2010. ,
DOI : 10.1016/j.autrev.2010.08.003
Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis, Clinical Rheumatology, vol.158, issue.2, pp.231-237, 2011. ,
DOI : 10.1111/j.1365-2133.2007.08392.x
Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1, J Rheumatol, vol.23, pp.291-296, 1996. ,
Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis, Scandinavian Journal of Rheumatology, vol.161, issue.2, pp.473-482, 2013. ,
DOI : 10.1146/annurev-pathol-011110-130312
Dysbalance of angiogenic and angiostatic mediators in patients with mixed connective tissue disease, Annals of the Rheumatic Diseases, vol.70, issue.7, pp.1197-1202, 2011. ,
DOI : 10.1136/ard.2010.140657
Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial, The Lancet, vol.378, issue.9790, pp.498-506, 2011. ,
DOI : 10.1016/S0140-6736(11)60982-3
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis, JAMA, vol.311, issue.24, pp.2490-2498, 2014. ,
DOI : 10.1001/jama.2014.6368
Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis, Arthritis & Rheumatism, vol.50, issue.5, pp.1555-1563, 2005. ,
DOI : 10.4049/jimmunol.171.1.432
Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study, Bone Marrow Transplantation, vol.176, issue.3, pp.349-354, 2014. ,
DOI : 10.1016/S0140-6736(11)61100-8
Analysis of immune reconstitution after autologous CD34+ stem/progenitor cell transplantation for systemic sclerosis: predominant reconstitution of Th1 CD4+ T cells, Rheumatology, vol.138, issue.3, pp.944-952, 2011. ,
DOI : 10.1111/j.1365-2249.2004.02642.x
Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis, Annals of the Rheumatic Diseases, vol.67, issue.1, pp.98-104, 2008. ,
DOI : 10.1136/ard.2007.071464
Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations, Arthritis Research & Therapy, vol.11, issue.5, p.147, 2009. ,
DOI : 10.1186/ar2821
The interleukin-1, interleukin-2, interleukin-6 and tumour necrosis factor alpha serological levels in localised and systemic sclerosis, Rom J Intern Med, vol.36, pp.251-259, 1998. ,
Uncontrolled Expression of Vascular Endothelial Growth Factor and Its Receptors Leads to Insufficient Skin Angiogenesis in Patients With Systemic Sclerosis, Circulation Research, vol.95, issue.1, pp.109-116, 2004. ,
DOI : 10.1161/01.RES.0000134644.89917.96
Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis, New England Journal of Medicine, vol.370, issue.5, pp.433-443, 2014. ,
DOI : 10.1056/NEJMoa1114576